News

Article

Pharmaceutical Technology

Pharmaceutical Technology-11-15-2017
Volume2017 ebook
Issue 2
Pages: 26-30

Designing and Operating Flexible, High-Containment Vaccine Manufacturing

Author(s):

Thomas Page

A new facility type integrates next-generation mobile cleanroom systems.

Facilities for advanced therapies should be configurable to flexibly segregate production for late-stage and commercial multiproduct operation. Efficient design of a flexible and high-containment vaccine manufacturing facility that can meet all the challenges presented by the market requires a design philosophy that includes all the key control concepts: air, people, equipment, product, and liquid and solid waste. This article discusses best practices for such control and describes the use of modular, mobile cleanrooms.

Download the 

Vaccine Development and Manufacturing 2017 ebook

.

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 26–30

Citation

When referring to this article, please cite it as T. Page, "Designing and Operating Flexible, High-Containment Vaccine Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

Articles in this issue
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases
Designing and Operating Flexible, High-Containment Vaccine Manufacturing
Designing and Operating Flexible, High-Containment Vaccine Manufacturing
Using Human Challenge Trials to Develop Flu Vaccines
Using Human Challenge Trials to Develop Flu Vaccines
Making Vaccines Accessible
Making Vaccines Accessible
Moving to Closed Systems for Aseptic Processing
Moving to Closed Systems for Aseptic Processing
Cold Chain: Delivering Vaccines to Patients
Cold Chain: Delivering Vaccines to Patients
Accelerating Vaccine Development and Manufacturing
Accelerating Vaccine Development and Manufacturing
Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools
Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content
White House | Image Credit: © Zack Frank - stock.adobe.com
August 1st 2025

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

Patrick Lavery
If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 1st 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
automatic stainless steel pharmaceutical fermenter | Image Credit: ©gen_A - stock.adobe.com
August 1st 2025

In-line UV Spectrometry Monitoring in Cleaning Validation

John Schallom Brian Bosso Paul Lopolito Katie Frey Amy Thanavaro
The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 1st 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
medicine factory scientist worker work in Laboratory Plants Process. medical doctor working research in pharmaceutical industry. | Image Credit: ©Quality Stock Arts – stock.adobe.com
August 1st 2025

Interfering with Interventions in Aseptic Processing

James Agalloco
Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.
Sand running through the bulbs of an hourglass | Image Credit: © BillionPhotos.com - stock.adobe.com
August 1st 2025

Customizable Relationships Enhance Speed to Market

Patrick Lavery
While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.